Early cardiac perfusion defects after left-sided radiation therapy for breast cancer: is there a volume response? Orit Kaidar-PersonTimothy M. ZagarLawrence B. Marks Review 21 April 2017 Pages: 253 - 262
Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications Jessica A. Cintolo-GonzalezDanielle BraunKevin S. Hughes Review 25 April 2017 Pages: 263 - 284
The role of quantitative estrogen receptor status in predicting tumor response at surgery in breast cancer patients treated with neoadjuvant chemotherapy Jacques RaphaelSonal GandhiMaureen Trudeau Review 02 May 2017 Pages: 285 - 294
Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia Alvaro PeñaSejal S. ShahAmy C. Degnim Review 04 May 2017 Pages: 295 - 304
Image analysis of immune cell patterns in the human mammary gland during the menstrual cycle refines lymphocytic lobulitis Nadine S. SchaadtJuan Carlos López AlfonsoFriedrich Feuerhake Preclinical study 25 April 2017 Pages: 305 - 315
Phenotypic characterisation of breast cancer: the role of CDC42 Eleni ChrysanthouKylie L. GorringeAbhik Mukherjee Preclinical study Open access 27 April 2017 Pages: 317 - 325
Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells Jie YuanYi YangRuifang Niu Preclinical study 03 May 2017 Pages: 327 - 340
Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections Abir A. MuftahMohammed A. AleskandaranyAndrew R. Green Preclinical study Open access 06 May 2017 Pages: 341 - 348
Development of mammary hyperplasia, dysplasia, and invasive ductal carcinoma in transgenic mice expressing the 8p11 amplicon oncogene NSD3 Brittany Turner-IveyEricka L. SmithStephen P. Ethier Preclinical study 08 May 2017 Pages: 349 - 358
Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2) Cornelia von HagensIngeborg Walter-SackThomas Strowitzki Clinical trial 24 April 2017 Pages: 359 - 369
Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32 Ana Elisa LohmannMira F. LiebmanFrom the CCTG, Alliance, SWOG, ECOG, NSABP Cooperative Groups Clinical trial 26 April 2017 Pages: 371 - 378
Effects of hepatitis C virus infection on the safety of chemotherapy for breast cancer patients Yu LiuZhan-Yi LiYong Huang Clinical Trial 26 April 2017 Pages: 379 - 383
The potential role of three-dimensional surface imaging as a tool to evaluate aesthetic outcome after Breast Conserving Therapy (BCT) Rachel L. O’ConnellRosa Di MiccoJennifer E. Rusby Clinical trial Open access 26 April 2017 Pages: 385 - 393
Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancer A. SheriI. E. SmithM. Dowsett Clinical trial Open access 26 April 2017 Pages: 395 - 400
Abbreviated breast dynamic contrast-enhanced MR imaging for lesion detection and characterization: the experience of an Italian oncologic center Antonella PetrilloRoberta FuscoGerardo Botti Clinical Trial 26 April 2017 Pages: 401 - 410
Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors Kunal C. KadakiaKelley M. KidwellN. Lynn Henry Clinical trial 27 April 2017 Pages: 411 - 419
Objective breast symmetry analysis with the breast analyzing tool (BAT): improved tool for clinical trials Wilfried KroisAlexander Ken RomarFlorian Fitzal Clinical trial Open access 02 May 2017 Pages: 421 - 427
Breast cancer treatment costs in younger, privately insured women Benjamin T. AllaireDonatus U. EkwuemeJustin G. Trogdon Epidemiology 21 April 2017 Pages: 429 - 436
Preoperative prediction of the size of pure ductal carcinoma in situ using three imaging modalities as compared to histopathological size: does magnetic resonance imaging add value? Ojuka Kinyuru DanielSung Mook LimSeung Il Kim Epidemiology 24 April 2017 Pages: 437 - 444
The Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaLuAtion (UMBRELLA): objectives, design, and baseline results D. A. Young-AfatC. H. van Gilson behalf of the UMBRELLA Study Group Epidemiology Open access 25 April 2017 Pages: 445 - 450
Metabolic factors, anthropometric measures, diet, and physical activity in long-term breast cancer survivors: change from diagnosis and comparison to non-breast cancer controls Ana Elisa LohmannMarguerite EnnisPamela J. Goodwin Epidemiology 25 April 2017 Pages: 451 - 460
A breast cancer gene signature for indolent disease Leonie J. M. J. DelahayeCaroline A. DrukkerAnnuska M. Glas Epidemiology Open access 27 April 2017 Pages: 461 - 466
Mammographic breast density and breast cancer risk in a Mediterranean population: a nested case–control study in the EPIC Florence cohort Giovanna MasalaDaniela AmbrogettiDomenico Palli Epidemiology 06 May 2017 Pages: 467 - 473
Interaction of insulin-like growth factor-I and insulin resistance-related genetic variants with lifestyle factors on postmenopausal breast cancer risk Su Yon JungGloria HoCarolyn Crandall Epidemiology 06 May 2017 Pages: 475 - 495
Characterization of a new BRCA1 rearrangement in an Italian woman with hereditary breast and ovarian cancer syndrome Paola ConcolinoRoberta RizzaEttore Capoluongo Brief Report 09 May 2017 Pages: 497 - 503
